Meinong Biotechnology Co., Ltd.

Announcement on the Implementation of 2025 Annual Equity Distribution

Announcement on the Cancellation of Certain Fundraising Special Accounts

Announcement on the completion of the board of directors' re-election and the appointment of senior management, securities affairs representative, and head of the audit department

Legal opinion from Beijing Tianyuan Law Firm regarding the 2025 Annual Shareholders' Meeting of Shanghai Meinong Biotechnology Co., Ltd.

Announcement of the resolution of the first meeting of the sixth board of directors

Announcement of the resolution of the 2025 Annual Shareholders' Meeting

On-site Inspection Report for the 2025 Annual Report from Zhongtai Securities Co., Ltd. Regarding Shanghai Meinong Biotechnology Co., Ltd.

Tracking Report for the 2025 Annual Report from Zhongtai Securities Co., Ltd. Regarding Shanghai Meinong Biotechnology Co., Ltd.

Summary Report from Zhongtai Securities Co., Ltd. Regarding Shanghai Meinong Biotechnology Co., Ltd.'s Initial Public Offering and Continuous Supervision

2025 Annual Independent Director Work Report - Xiang Chuan

2025 Annual Independent Director Work Report - Liu Junling

2025 Annual Independent Director Work Report - Deng Gang

Announcement on Holding the 2025 Online Performance Briefing

CITIC Securities Co., Ltd. Verification Opinion on Shanghai Meinong Biotechnology Co., Ltd. 2025 Annual Internal Control Self-Assessment Report

Internal Control Audit Report

2025 Annual Internal Control Self-Assessment Report

Announcement on the Revision of the Articles of Association

Announcement on the Revision and Formulation of Relevant Company Systems

Compensation Management System for Directors and Senior Management

Management System for Resignation of Directors and Senior Management

Work System for Independent Directors

Management System for External Investments

Management System for External Guarantees

Management System for Raised Funds

Cumulative Voting System

Information Disclosure Management System

Internal Audit Work System

Insider Information Knowledge Person Registration Management System

Investor Relations Management System

Temporary Suspension and Exemption Management System for Information Disclosure

Articles of Association

Rules of Procedure for Board Meetings

Management Measures for Related Transactions

Rules of Procedure for Shareholders' Meetings

Announcement on the Compensation Plan for Directors and Senior Management

Announcement on the Provision for Asset Impairment for the First Quarter of 2026

Declaration and Commitment of Independent Director Candidate - Xiang Chuan

Declaration and Commitment of Independent Director Candidate - Liu Junling

Declaration and Commitment of Independent Director Candidate - Deng Gang

Declaration and Commitment of Independent Director Nominee - Xiang Chuan

Declaration and Commitment of Independent Director Nominee - Deng Gang

Declaration and Commitment of Independent Director Nominee - Liu Junling

Announcement on the Election of the Board of Directors

Special Verification Opinion from Zhongtai Securities Co., Ltd. on the Completion of Fundraising Projects and the Permanent Supplementation of Remaining Raised Funds to Working Capital for Shanghai Meinong Biotechnology Co., Ltd.

Announcement on the Completion of Fundraising Investment Projects and the Permanent Supplementation of Remaining Raised Funds to Working Capital

Special Verification Opinion from Zhongtai Securities Co., Ltd. on the Storage and Use of Raised Funds for Shanghai Meinong Biotechnology Co., Ltd. in 2025

Announcement on the Confirmation of Routine Related Transactions for 2025 and the Estimated Routine Related Transactions for 2026

Announcement on Adjustments to External Investment Projects and the Transfer of Some Idle Land Use Rights by Subsidiaries

Announcement on Applying for Comprehensive Credit Limits and Guarantees from Financial Institutions

Feasibility Analysis Report on the Development of Hedging Business

Announcement on the Development of Hedging Business

Notice of the 2025 Annual Shareholders' Meeting

Announcement of Resolutions from the 17th Meeting of the 5th Board of Directors

2025 Board of Directors Work Report

Announcement on the Profit Distribution Plan for 2025

Announcement on Requesting Shareholder Meeting Authorization for the Board of Directors to Decide on the 2026 Mid-term Dividend Plan

2026 First Quarter Report

Special Report on the Storage, Management, and Use of Raised Funds for 2025

Verification Report on the Annual Storage, Management, and Use of Raised Funds

Report on the Evaluation of the Performance of the Accounting Firm for 2025 and the Audit Committee's Supervision Responsibilities

Special Explanation on Non-operating Fund Occupation and Other Related Fund Transactions

Summary Table of Non-operating Fund Occupation and Other Related Fund Transactions for 2025

Special Opinion of the Board of Directors on the Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on the Use of Idle Self-owned Funds for Cash Management

Announcement on increasing the estimated amount of daily related party transactions for 2025

Resolution announcement of the sixteenth meeting of the fifth board of directors

Announcement on the change of the continuous supervision sponsor representative